Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 368

1.

Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A.

Gianferante DM, Wlodarski MW, Atsidaftos E, Da Costa L, Delaporta P, Farrar JE, Goldman FD, Hussain M, Kattamis A, Leblanc T, Lipton JM, Niemeyer CM, Pospisilova D, Quarello P, Ramenghi U, Sankaran VG, Vlachos A, Volejnikova J, Alter BP, Savage SA, Giri N.

Haematologica. 2020 Apr 2. pii: haematol.2020.246629. doi: 10.3324/haematol.2020.246629. [Epub ahead of print]

PMID:
32241839
2.

Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.

Sung AD, Jauhari S, Siamakpour-Reihani S, Rao AV, Staats J, Chan C, Meyer E, Gadi VK, Nixon AB, Lyu J, Xie J, Bohannon L, Li Z, Hourigan CS, Dillon LW, Wong HY, Shelby R, Diehl L, de Castro C, LeBlanc T, Brander D, Erba H, Galal A, Stefanovic A, Chao N, Rizzieri DA.

Am J Hematol. 2020 Mar 12. doi: 10.1002/ajh.25781. [Epub ahead of print]

PMID:
32162718
3.

Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.

Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, Bayart S, Bertrand Y, Michel G, Jeziorski E, Thomas C, Abouchallah W, Viard F, Guitton C, Cheikh N, Pellier I, Carausu L, Droz C, Leblanc T, Aladjidi N; Centre de Référence National des Cytopénies Auto-immunes de l’Enfant (CEREVANCE).

Br J Haematol. 2020 Mar 4. doi: 10.1111/bjh.16448. [Epub ahead of print]

PMID:
32130726
4.

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group.

Daw S, Hasenclever D, Mascarin M, Fernández-Teijeiro A, Balwierz W, Beishuizen A, Burnelli R, Cepelova M, Claviez A, Dieckmann K, Landman-Parker J, Kluge R, Körholz D, Mauz-Körholz C, Wallace WH, Leblanc T.

Hemasphere. 2020 Jan 10;4(1):e329. doi: 10.1097/HS9.0000000000000329. eCollection 2020 Feb.

5.

Palliative care in hematologic malignancies: a multidisciplinary approach.

Gatta B, LeBlanc TW.

Expert Rev Hematol. 2020 Mar;13(3):223-231. doi: 10.1080/17474086.2020.1728248. Epub 2020 Feb 17.

PMID:
32066301
6.

Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study.

Bryant AL, LeBlanc TW, Albrecht T, Chan YN, Richardson J, Foster M, Dang M, Dudley W, Owenby S, Wujcik D.

Support Care Cancer. 2020 Feb 14. doi: 10.1007/s00520-020-05349-5. [Epub ahead of print]

PMID:
32060702
7.

An analysis of missing items in real-world electronic patient reported outcomes data: implications for clinical care.

Rosett HA, Locke SC, Wolf SP, Herring KW, Samsa GP, Troy JD, LeBlanc TW.

Support Care Cancer. 2020 Feb 10. doi: 10.1007/s00520-020-05338-8. [Epub ahead of print]

PMID:
32040637
8.

Palliative and End-of-Life Care for Patients With Hematologic Malignancies.

El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW.

J Clin Oncol. 2020 Mar 20;38(9):944-953. doi: 10.1200/JCO.18.02386. Epub 2020 Feb 5.

PMID:
32023164
9.

A Spatial and Temporal Investigation of Medical Surge in Dallas-Fort Worth During Hurricane Harvey, Texas 2017.

Stephens W, Wilt GE, Lehnert EA, Molinari NM, LeBlanc TT.

Disaster Med Public Health Prep. 2020 Feb;14(1):111-118. doi: 10.1017/dmp.2019.143.

PMID:
31996271
10.

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group.

Blais S, Boutroux H, Pasquet M, Leblanc T, Fenneteau O, Gandemer V, Bertrand Y, Ducassou S, Michel G, Nelken B, Petit A, Cuccuini W, Gouache E, Renaut MA, Baruchel A, Lapillonne H, Leverger G.

Hemasphere. 2019 Oct 30;3(6):e316. doi: 10.1097/HS9.0000000000000316. eCollection 2019 Dec.

11.

HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children.

Joly BS, Loiseau P, Darmon M, Leblanc T, Chambost H, Fouyssac F, Guigonis V, Harambat J, Stepanian A, Coppo P, Veyradier A.

Haematologica. 2020 Jan 16. pii: haematol.2019.241968. doi: 10.3324/haematol.2019.241968. [Epub ahead of print] No abstract available.

12.

Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey.

Delehaye F, Habes D, Dourthe ME, Bertrand Y, Michel G, Gaudichon J, Debray D, Nelken B, Pasquet M, Blanche S, Leblanc T.

Pediatr Blood Cancer. 2020 Apr;67(4):e28177. doi: 10.1002/pbc.28177. Epub 2020 Jan 11.

PMID:
31925926
13.

How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.

LeBlanc MR, Hirschey R, Leak Bryant A, LeBlanc TW, Smith SK.

Qual Life Res. 2019 Dec 17. doi: 10.1007/s11136-019-02392-6. [Epub ahead of print] Review.

PMID:
31848847
14.

Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study.

Loh KP, Xu H, Back A, Duberstein PR, Gupta Mohile S, Epstein R, McHugh C, Klepin HD, Abel G, Lee SJ, El-Jawahri A, LeBlanc TW.

Cancer. 2020 Mar 15;126(6):1306-1314. doi: 10.1002/cncr.32656. Epub 2019 Dec 6.

PMID:
31809566
15.

Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute Care.

Navari RM, Ruddy KJ, LeBlanc TW, Clark-Snow R, Wickham RJ, Binder G, Coberly T, Potluri R, Schmerold LM, Roeland EJ.

JCO Oncol Pract. 2020 Feb;16(2):e132-e138. doi: 10.1200/JOP.19.00457. Epub 2019 Dec 4.

PMID:
31800352
16.

Ribosomal protein gene RPL9 variants can differentially impair ribosome function and cellular metabolism.

Lezzerini M, Penzo M, O'Donohue MF, Marques Dos Santos Vieira C, Saby M, Elfrink HL, Diets IJ, Hesse AM, Couté Y, Gastou M, Nin-Velez A, Nikkels PGJ, Olson AN, Zonneveld-Huijssoon E, Jongmans MCJ, Zhang G, van Weeghel M, Houtkooper RH, Wlodarski MW, Kuiper RP, Bierings MB, van der Werff Ten Bosch J, Leblanc T, Montanaro L, Dinman JD, Da Costa L, Gleizes PE, MacInnes AW.

Nucleic Acids Res. 2020 Jan 24;48(2):770-787. doi: 10.1093/nar/gkz1042.

17.

Integration of Palliative Care into Acute Myeloid Leukemia Care.

Webb JA, LeBlanc TW, El-Jawahri AR.

Semin Oncol Nurs. 2019 Dec;35(6):150959. doi: 10.1016/j.soncn.2019.150959. Epub 2019 Nov 22. Review.

PMID:
31767262
18.

Shared Decision-making in Acute Myeloid Leukemia.

LeBlanc TW.

Semin Oncol Nurs. 2019 Dec;35(6):150958. doi: 10.1016/j.soncn.2019.150958. Epub 2019 Nov 20. Review.

PMID:
31759817
19.

Introduction.

Bryant AL, LeBlanc TW.

Semin Oncol Nurs. 2019 Dec;35(6):150961. doi: 10.1016/j.soncn.2019.150961. Epub 2019 Nov 15. No abstract available.

PMID:
31740088
20.

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial.

Petit A, Ducassou S, Leblanc T, Pasquet M, Rousseau A, Ragu C, Cachanado M, Nelken B, Bertrand Y, Michel G, Gandemer V, Cuccuini W, Fenneteau O, Lapillonne H, Auvrignon A, Baruchel A, Leverger G.

Hemasphere. 2018 Nov 29;2(6):e159. doi: 10.1097/HS9.0000000000000159. eCollection 2018 Dec.

21.

Analysis of Escherichia coli and Listeria monocytogenes Isolate Subtyping and Reporting Capacity by Public Health Laboratories, United States (2013-2017).

Martinez D, LeBlanc TT, Hise KB.

J Public Health Manag Pract. 2019 Oct 4. doi: 10.1097/PHH.0000000000001098. [Epub ahead of print]

PMID:
31592988
22.

Managing the Unusual Causes of Fetal Anemia.

Maisonneuve E, Ben M'Barek I, Leblanc T, Da Costa L, Friszer S, Pernot F, Thomas P, Castaigne V, Toly N'Dour C, Mailloux A, Cortey A, Jouannic JM.

Fetal Diagn Ther. 2020;47(2):156-164. doi: 10.1159/000501554. Epub 2019 Sep 10.

PMID:
31505487
23.

Community Preparedness for Public Health Emergencies: Introduction and Contents of the Volume.

Avchen RN, Kosmos C, LeBlanc TT.

Am J Public Health. 2019 Sep;109(S4):S253-S255. doi: 10.2105/AJPH.2019.305316. No abstract available.

24.

The Virtual Village: A 21st-Century Challenge for Community Preparedness.

LeBlanc TT, Ekperi L, Kosmos C, Avchen RN.

Am J Public Health. 2019 Sep;109(S4):S258-S259. doi: 10.2105/AJPH.2019.305277. No abstract available.

25.

Preassessment of Community-Based Organization Preparedness in Two Sectors, Human Services and Faith Based: New York City, 2016.

Rivera L, Pagaoa M, Molinari NA, Morgenthau BM, LeBlanc TT.

Am J Public Health. 2019 Sep;109(S4):S290-S296. doi: 10.2105/AJPH.2019.305141.

26.

Participation in Community Preparedness Programs in Human Services Organizations and Faith-Based Organizations - New York City, 2018.

Rivera L, Pagaoa M, Morgenthau BM, Paquet C, Molinari NAM, LeBlanc TT.

MMWR Morb Mortal Wkly Rep. 2019 Sep 6;68(35):757-761. doi: 10.15585/mmwr.mm6835a2.

27.

Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

Fouquet C, Le Rouzic MA, Leblanc T, Fouyssac F, Leverger G, Hessissen L, Marlin S, Bourrat E, Fahd M, Raffoux E, Vannier JP, Jäkel N, Knoefler R, Triolo V, Pasquet M, Bayart S, Thuret I, Lutz P, Vermylen C, Touati M, Rose C, Matthes T, Isidor B, Kannengiesser C, Ducassou S.

Br J Haematol. 2019 Nov;187(4):530-542. doi: 10.1111/bjh.16100. Epub 2019 Jul 23.

PMID:
31338833
28.

Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Hematologic Malignancies.

Webb JA, Foxwell AM, Jones CA, El-Jawahri A, Kamal AH, Kayastha N, Roeland EJ, LeBlanc TW.

J Palliat Med. 2019 Nov;22(11):1449-1454. doi: 10.1089/jpm.2019.0332. Epub 2019 Jul 19.

PMID:
31329005
29.

Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials.

LeBlanc TW.

Leuk Lymphoma. 2019 Nov;60(11):2604-2605. doi: 10.1080/10428194.2019.1632446. Epub 2019 Jul 4. No abstract available.

PMID:
31271323
30.

A New Frontier for Palliative Care: The Need to Train Palliative-Oncology Subspecialists.

Webb JA, Kamal AH, LeBlanc TW.

J Palliat Med. 2018 Dec;21(12):1679-1680. doi: 10.1089/jpm.2018.0421. No abstract available.

PMID:
31219413
31.

Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.

Rigaud C, Auperin A, Jourdain A, Haouy S, Couec ML, Aladjidi N, Gandemer V, Lambliotte A, Plat G, Landman-Parker J, Michon J, Leblanc T, Patte C, Minard-Colin V.

Pediatr Blood Cancer. 2019 Sep;66(9):e27873. doi: 10.1002/pbc.27873. Epub 2019 Jun 17.

PMID:
31207026
32.

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D, Coutre SE, De Lima M, Fathi AT, Fiorella M, Foran JM, Hall AC, Jacoby M, Lancet J, LeBlanc TW, Mannis G, Marcucci G, Martin MG, Mims A, O'Donnell MR, Olin R, Peker D, Perl A, Pollyea DA, Pratz K, Prebet T, Ravandi F, Shami PJ, Stone RM, Strickland SA, Wieduwilt M, Gregory KM; OCN, Hammond L, Ogba N.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):721-749. doi: 10.6004/jnccn.2019.0028.

PMID:
31200351
33.

Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation.

Poirot C, Fortin A, Lacorte JM, Akakpo JP, Genestie C, Vernant JP, Brice P, Morice P, Leblanc T, Gabarre J, Delmer A, Badachi Y, Drouineaud V, Gouy S, Chalas C, Egels S, Dhédin N, Touraine P, Dommergues M, Lebègue G, Wolf JP, Capron F, Lefebvre G, Boissel N; CAROLéLISA Cooperative Group.

Hum Reprod. 2019 Jun 4;34(6):1083-1094. doi: 10.1093/humrep/dez047.

PMID:
31116405
34.

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies.

LeBlanc TW, Baile WF, Eggly S, Bylund CL, Kurtin S, Khurana M, Najdi R, Blaedel J, Wolf JL, Fonseca R.

Patient Educ Couns. 2019 Sep;102(9):1602-1612. doi: 10.1016/j.pec.2019.04.028. Epub 2019 Apr 26. Review.

PMID:
31076236
35.

Unintentional weight loss, its associated burden, and perceived weight status in people with cancer.

Yuen EYN, Zaleta AK, McManus S, Buzaglo JS, LeBlanc TW, Hamilton K, Stein K.

Support Care Cancer. 2020 Jan;28(1):329-339. doi: 10.1007/s00520-019-04797-y. Epub 2019 May 2.

PMID:
31049669
36.

Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes.

Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magérus-Chatinet A, Mazerolles F, Stolzenberg MC, Jacques S, Picard C, Rosain J, Fourrage C, Hanein S, Zarhrate M, Pasquet M, Abou Chahla W, Barlogis V, Bertrand Y, Pellier I, Colomb Bottollier E, Fouyssac F, Blouin P, Thomas C, Cheikh N, Dore E, Pondarre C, Plantaz D, Jeziorski E, Millot F, Garcelon N, Ducassou S, Perel Y, Leblanc T, Neven B, Fischer A, Rieux-Laucat F; members of the French Reference Center for Pediatric Autoimmune Cytopenia (CEREVANCE).

Blood. 2019 Jul 4;134(1):9-21. doi: 10.1182/blood-2018-11-887141. Epub 2019 Apr 2.

PMID:
30940614
37.

Shifting paradigms in the treatment of older adults with AML.

LeBlanc TW, Erba HP.

Semin Hematol. 2019 Apr;56(2):110-117. doi: 10.1053/j.seminhematol.2019.02.002. Epub 2019 Feb 27. Review.

PMID:
30926086
38.

Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.

El-Jawahri A, Abel GA, Traeger L, Waldman L, Markovitz N, VanDusen H, Fathi A, Steensma DP, LeBlanc TW, Horick NK, DeAngelo DJ, Wadleigh M, Hobbs G, Foster J, Brunner AM, Amrein P, Stone RM, Temel JS, Greer JA.

Leukemia. 2019 Oct;33(10):2393-2402. doi: 10.1038/s41375-019-0449-1. Epub 2019 Mar 28.

PMID:
30923318
39.

Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.

Sarasin A, Quentin S, Droin N, Sahbatou M, Saada V, Auger N, Boursin Y, Dessen P, Raimbault A, Asnafi V, Schmutz JL, Taïeb A, Menck CFM, Rosselli F, La Rochelle LD, Robert C, Sicre de Fontbrune F, Sébert M, Leblanc T, Kannouche P, De Botton S, Solary E, Soulier J.

Blood. 2019 Jun 20;133(25):2718-2724. doi: 10.1182/blood-2019-01-895698. Epub 2019 Mar 26. No abstract available.

40.

Prognostication and Communication in Oncology.

LeBlanc TW, Marron JM, Ganai S, McGinnis MM, Spence RA, Tenner L, Tap WD, Hlubocky FJ.

J Oncol Pract. 2019 Apr;15(4):208-215. doi: 10.1200/JOP.18.00647. Epub 2019 Mar 25. No abstract available.

PMID:
30908141
41.

Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective.

Aapro M, Zhang L, Yennu S, LeBlanc TW, Schwartzberg L.

Future Oncol. 2019 Apr;15(10):1067-1084. doi: 10.2217/fon-2018-0872. Epub 2019 Mar 12.

42.

Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study.

Porter LS, Samsa G, Steel JL, Hanson LC, LeBlanc TW, Bull J, Fischer S, Keefe FJ.

Clin Trials. 2019 Jun;16(3):263-272. doi: 10.1177/1740774519829695. Epub 2019 Feb 19.

PMID:
30782014
43.

Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies.

Poirot C, Fortin A, Dhédin N, Brice P, Socié G, Lacorte JM, Akakpo JP, Genestie C, Vernant JP, Leblanc T, Gabarre J, Delmer A, Badachi Y, Drouineaud V, Chalas C, Egels S, Touraine P, Dommergues M, Lebègue G, Wolf JP, Capron F, Lefebvre G, Boissel N.

Haematologica. 2019 Aug;104(8):e360-e363. doi: 10.3324/haematol.2018.211094. Epub 2019 Feb 14. No abstract available.

44.

Pruritus in patients with solid tumors: an overlooked supportive care need.

Vallely JJ, Hudson KE, Locke SC, Wolf SP, Samsa GP, Abernethy AP, LeBlanc TW.

Support Care Cancer. 2019 Oct;27(10):3897-3904. doi: 10.1007/s00520-019-04693-5. Epub 2019 Feb 14.

PMID:
30762144
45.

Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients.

Derry HM, Maciejewski PK, Epstein AS, Shah MA, LeBlanc TW, Reyna V, Prigerson HG.

J Palliat Med. 2019 Aug;22(8):961-965. doi: 10.1089/jpm.2018.0624. Epub 2019 Feb 6.

PMID:
30724692
46.

Disparities in place of death for patients with hematological malignancies, 1999 to 2015.

Chino F, Kamal AH, Chino J, LeBlanc TW.

Blood Adv. 2019 Feb 12;3(3):333-338. doi: 10.1182/bloodadvances.2018023051.

47.

Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1.

Rio S, Gastou M, Karboul N, Derman R, Suriyun T, Manceau H, Leblanc T, El Benna J, Schmitt C, Azouzi S, Larghéro J, Karim Z, Macias-Garcia A, Chen JJ, Hermine O, Courtois G, Puy H, Gouya L, Mohandas N, Da Costa L.

Blood. 2019 Mar 21;133(12):1358-1370. doi: 10.1182/blood-2018-09-875674. Epub 2019 Jan 30.

48.

Korean Physicians' Perspectives on Prognostication in Palliative Care: A Qualitative Study.

Lee ES, Suh SY, LeBlanc TW, Himchack SH, Lee SS, Kim Y, Ahn HY.

Am J Hosp Palliat Care. 2019 Jun;36(6):500-506. doi: 10.1177/1049909118824542. Epub 2019 Jan 27.

PMID:
30686024
49.

Neurological Involvement in Childhood Evans Syndrome.

Pincez T, Neven B, Le Pointe HD, Varlet P, Fernandes H, Gareton A, Leverger G, Leblanc T, Chambost H, Michel G, Pasquet M, Millot F, Hermine O, Mathian A, Hully M, Zephir H, Hamidou M, Durand JM, Perel Y, Landman-Parker J, Rieux-Laucat F, Aladjidi N.

J Clin Immunol. 2019 Feb;39(2):171-181. doi: 10.1007/s10875-019-0594-3. Epub 2019 Jan 22.

50.

Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

Tenner L, Hlubocky FJ, Blanke CD, LeBlanc TW, Marron JM, McGinnis MM, Spence RA, Taylor LP.

J Oncol Pract. 2019 Jan;15(1):44-49. doi: 10.1200/JOP.18.00432. Erratum in: J Oncol Pract. 2019 Mar;15(3):162.

Supplemental Content

Loading ...
Support Center